30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Sanofi Reports 3Q16 Synvisc Revenue -

Sanofi posted 3Q16 Synvisc viscosupplementation product revenue of €100.0MM (~US $111.6MM), +3.8% from 3Q15, as-reported. 

Source: Sanofi*

*To view Synvisc results from this page, please select the Excel spreadsheet titled Q3 & 9M 2016 net sales and aggregate Group sales by GBU, franchise, geographic region and product

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.